Immunoregulatory Engineering of Semiconducting Charge‐Reversal Nanoantioxidant for Ameliorating Cancer Radioimmunotheranostics
Advanced Materials · 2024-08 · 36 (31)
DOI: 10.1002/adma.202402929 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 16.06.2024. Verfasst von Wen Ma und 7 weiteren Autor:innen. Beteiligte Einrichtung: Strait Laboratory of Flexible Electronics (SLoFE), Fujian Key Laboratory of Flexible Electronics, Strait Institute of Flexible Electronics (SIFE, Fut…. Hauptthemen laut MEDLINE: Antioxidants. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Fujian Normal University, Natural Science Foundation of Fujian Province.
Abstract (Originalsprache)
Radiotherapy (RT) is a crucial clinical modality for cancer. However, nonselectivity, toxicity to normal tissues, and radio‐resistance severely limit RT applications. This study develops a versatile X‐ray theranostic nano‐antioxidant (XTN) to prevent normal tissues from oxidative damage and induce systematic and robust anticancer immunity. XTN owns NIR‐II photoacoustic (PA) imaging properties for precise discrimination of the tumor margin through, thereby improving the accuracy of RT. Additionally, XTN is a nano‐antioxidant to enhance the cell viability of normal cells after irradiation. Most importantly, XTN scavenges reactive oxygen species (ROS) in the TME to preserve the stimulatory activity of released high mobility group protein B1 to dendritic cells (DCs) and recover T cells’ immune function. Meanwhile, XTN achieves charge‐reversal specifically releasing an immunomodulator (demethylcantharidin, DMC) in the acidic TME. Moreover, the specifically released DMC inhibits protein phosphatase‐2A activity and reduces regulatory T cell (Treg) differentiation. In the bilateral 4T1 tumor model, XTN‐mediated radioimmunotherapy remarkably boosts a systemic antitumor immune response and induces durable immunological memory against tumor growth.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Strait Laboratory of Flexible Electronics (SLoFE), Fujian Key Laboratory of Flexible Electronics, Strait Institute of Flexible Electronics (SIFE, Future Technologies), Fujian Normal University, Fuzhou, Fujian, 350117, C…
- State Key Laboratory of Vaccines for Infectious Diseases, Xiang an Biomedicine Laboratory, Center for Molecular Imaging and Translational Medicine, School of Public Health, Xiamen University, Xiamen, 361102, China.
- Department of Laboratory Medicine, Dongguan Institute of Clinical Cancer Research, Affiliated Dongguan Hospital, Southern Medical University, Dongguan, Guangdong, 523018, China.
- Frontiers Science Center for Flexible Electronics, Xi'an Institute of Flexible Electronics (IFE), Northwestern Polytechnical University, Xi'an, 710072, China.
ORCID-Profile: Zhen Yang
Förderung
- National Natural Science Foundation of China
- Fujian Normal University
- Natural Science Foundation of Fujian Province
- Dongguan Science and Technology of Social Development Program
- animal experiment procedures were conducted following an approved protocol
Zitieren
APA
Ma, W., Luo, H., Lv, J., Wen, P., Liu, G., Yu, Z., Yang, Z., & Huang, W. (2024). Immunoregulatory Engineering of Semiconducting Charge‐Reversal Nanoantioxidant for Ameliorating Cancer Radioimmunotheranostics. Advanced Materials, 36(31). https://doi.org/10.1002/adma.202402929
Vancouver
Ma W, Luo H, Lv J, Wen P, Liu G, Yu Z, et al. Immunoregulatory Engineering of Semiconducting Charge‐Reversal Nanoantioxidant for Ameliorating Cancer Radioimmunotheranostics. Advanced Materials. 2024;36(31). doi:10.1002/adma.202402929
BibTeX
@article{Ma2024,
author = {Ma, Wen and Luo, Haifen and Lv, Jingqi and Wen, Peiye and Liu, Gang and Yu, Zhiqiang and Yang, Zhen and Huang, Wei},
title = {Immunoregulatory Engineering of Semiconducting Charge‐Reversal Nanoantioxidant for Ameliorating Cancer Radioimmunotheranostics},
journal = {Advanced Materials},
year = {2024},
volume = {36},
number = {31},
doi = {10.1002/adma.202402929}
}
EUVIMED